论文部分内容阅读
我们于1996年5月至1997年5月分别用达纳康和维脑路通治疗急性脑梗死91例,并进行了临床与血液流变学观察,结果报告如下。 对象与方法 1.对象 91例均为住院患者,按住院先后次序分为两组。治疗组46例,男34例、女12例,年龄42～86岁,平均55.3岁。按神经功能缺损评分:重型6例(13％)、中型25例(54％)、轻型15例(33％)。对照组45例,男36例、女9例,年龄48～82岁,平均56.1岁。其中重型5例(11％)、中型27例(60％)、轻型13例(29％)。病程自发病至治疗时间
We treated 91 cases of acute cerebral infarction with dacroner and Verapamil separately from May 1996 to May 1997 and conducted clinical and hemorheological observations. The results are reported as follows. Subjects and methods 1. Subjects 91 cases were hospitalized patients, according to the order of hospitalization is divided into two groups. The treatment group of 46 patients, 34 males and 12 females, aged 42 to 86 years, mean 55.3 years. According to neurological deficit score, 6 cases were severe (13%), 25 cases were medium (54%) and 15 cases were light (33%). Control group, 45 cases, 36 males and 9 females, aged 48 to 82 years, mean 56.1 years. Among them, 5 were severe (11%), 27 were medium (60%) and 13 were light (29%). Course of disease from onset to treatment time